NetraMark wins phase 3 clinical trial contract from global biopharma
Tweet Send to a Friend
NetraMark Holdings Inc. (CSE: AIAI) (OTCQB: AINMF) announced it secured a contract from a global biopharmaceutical company to provide analytics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


